CONSOLIDATED STATEMENTS OF CASH FLOWS UNAUDITED - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Loss from disposition	$ 0	$ (520)
Gains (Losses) on Extinguishment of Debt	0	(8,414)
Cash flows from operating activities:
Net income (loss)	111,359	85,745
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	0	39,139
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation expense	29,616	28,277
Amortization expense	36,119	38,820
Changes in assets and liabilities, net of effects from acquisition and divestiture of businesses:
Accounts receivable, net of provision for doubtful accounts	(48,613)	(14,436)
Inventories	42,669	104,580
Other current and noncurrent assets	121,376	(10,418)
Accounts payable	74,092	71,429
Accrued employee compensation	9,433	12,851
Current and noncurrent liabilities	54,294	25,299
Net cash flows from operating activities of continuing operations	430,345	390,220
Net cash flows from operating activities of discontinued operations	0	6,160
Net cash flows from operating activities	430,345	396,380
Cash flows from investing activities:
Acquisition of businesses, net of cash received	(54,802)	0
Proceeds from Divestiture of Businesses	0	7,114
Capital expenditures	(27,664)	(48,023)
Payments for (Proceeds from) Other Investing Activities	0	40
Net cash flows used in investing activities of continuing operations	(82,466)	(40,869)
Net cash flows used in investing activities of discontinued operations	0	(730)
Net cash flows used in investing activities	(82,466)	(41,599)
Cash flows from financing activities:
Payments on Term Loans	(10,000)	(10,625)
Payments on long-term borrowings and obligations	(5,999)	(175,115)
Payments of Debt Issuance Costs	(2,239)	0
Increase (decrease) in cash overdraft balance	1,292	(6,870)
Payments for Omnicare common stock repurchases	(125,000)	(160,438)
Proceeds for stock awards and exercise of stock options, net of stock tendered in payment	(8,224)	(2,720)
Dividends paid	(42,362)	(38,979)
Other	5,562	4,121
Net Cash Provided by (Used in) Financing Activities	(186,970)	(390,626)
Net increase (decrease) in cash and cash equivalents	160,909	(35,845)
Increase (decrease) in cash and cash equivalents of discontinued operations	0	5,430
Increase (decrease) in cash and cash equivalents of continuing operations	160,909	(41,275)
Cash and cash equivalents at beginning of period	153,799	356,001
Cash and cash equivalents at end of period	$ 314,708	$ 314,726